NCT04903158

Relative Bioavailability Study of SHR3680

A Single-Center, Single-Dose, Randomized, Open-Label, Parallel Study of Relative Bioavailability With Oral Administration of New and Old Formulations of SHR3680 Tablets in Healthy Male Subjects Under Fasting Conditions

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: Male
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This is a single-center, single-dose, randomized, open-label, parallel sstudy to evaluate the relative bioavailability of new and old formulations of SHR3680 tablets in healthy male subjects under fasting conditions.

Conditions

• Healthy Male Subjects

Interventions

Type	Name	Description
DRUG	test SHR3680 tablets	Subjects receiving a single oral dose of SHR3680 tablets with 240mg (80mg\*3)
DRUG	reference SHR3680 tablets	subjects receiving a single oral dose of SHR3680 tablets with 240mg (100mg\*2+20mg\*2).

Timeline

• Start date: 2021-01-06
• Primary completion: 2021-03-15
• Completion: 2021-05-01
• First posted: 2021-05-26
• Last updated: 2021-05-26

Locations

1 site across 1 country: China